Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
出版年份 2015 全文链接
标题
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 26, Issue 6, Pages 1081-1090
出版商
Oxford University Press (OUP)
发表日期
2015-03-10
DOI
10.1093/annonc/mdv138
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
- (2014) P. J. Hesketh et al. ANNALS OF ONCOLOGY
- A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
- (2014) R. J. Gralla et al. ANNALS OF ONCOLOGY
- A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
- (2014) M. Aapro et al. ANNALS OF ONCOLOGY
- Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)
- (2014) Debra L. Barton et al. CANCER
- Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron?
- (2014) Luigi Celio et al. JOURNAL OF CLINICAL ONCOLOGY
- Aprepitant in patients with advanced non-small-cell lung cancer receiving carboplatin-based chemotherapy
- (2014) Yasuhiro Ito et al. LUNG CANCER
- Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines
- (2014) Shiying Yu et al. SUPPORTIVE CARE IN CANCER
- A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
- (2014) Hee Yeon Lee et al. Cancer Research and Treatment
- Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trial
- (2014) Tulla Spinelli et al. SpringerPlus
- Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study
- (2014) James W. Gilmore et al. Journal of Oncology Practice
- A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy
- (2013) M Tanioka et al. BRITISH JOURNAL OF CANCER
- Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT3 receptor antagonist palonosetron in the least shrew (Cryptotis parva)
- (2013) Nissar A. Darmani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): Content and implementation in daily routine practice
- (2013) Karin Jordan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Use of Statins and the Risk of Death in Patients With Prostate Cancer
- (2013) Oriana Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind Study
- (2013) Fausto Roila et al. JOURNAL OF CLINICAL ONCOLOGY
- Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3receptors of enteric neurons
- (2013) J. Walstab et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review
- (2013) Wolfgang M Marx et al. NUTRITION REVIEWS
- The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
- (2013) Rudolph M. Navari et al. SUPPORTIVE CARE IN CANCER
- The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- Prevention of Nausea and Vomiting Associated with Stem Cell Transplant: Results of a Prospective, Randomized Trial of Aprepitant Used with Highly Emetogenic Preparative Regimens
- (2012) Patrick J. Stiff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting
- (2012) Yunes Panahi et al. INTEGRATIVE CANCER THERAPIES
- Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy
- (2012) Joseph A. Roscoe et al. JOURNAL OF CLINICAL ONCOLOGY
- Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials
- (2012) Luigi Celio et al. SUPPORTIVE CARE IN CANCER
- Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study
- (2011) Felipe Melo Cruz et al. SUPPORTIVE CARE IN CANCER
- Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients
- (2011) Julie L. Ryan et al. SUPPORTIVE CARE IN CANCER
- Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
- (2010) F. Roila et al. ANNALS OF ONCOLOGY
- Antiemetic activity of megestrol acetate in patients receiving chemotherapy
- (2010) Jian Zang et al. SUPPORTIVE CARE IN CANCER
- Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
- (2010) Luigi Celio et al. SUPPORTIVE CARE IN CANCER
- Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
- (2009) Lijun Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
- (2009) Mitsue Saito et al. LANCET ONCOLOGY
- Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
- (2009) Bernardo L. Rapoport et al. SUPPORTIVE CARE IN CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More